Dalys Gomez, MD
Allergy/ Immunology · San Antonio, TXNPI 1558367508
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 25.5% of the total.
Across 313 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- GSK$1K
- CSL Behring$756
- Grifols USA, LLC$345
- AstraZeneca$221
- Shire North American Group Inc$205
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,550100%
- Education$240%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 66 | $1,421 |
| GSK | 80 | $1,119 |
| CSL Behring | 45 | $756 |
| Grifols USA, LLC | 19 | $345 |
| AstraZeneca | 12 | $221 |
| Shire North American Group Inc | 12 | $205 |
| Optinose US, Inc. | 10 | $177 |
| Octapharma USA, Inc. | 9 | $170 |
| Novartis | 6 | $153 |
| Alk-abello, Inc | 9 | $150 |
| Biocryst US Sales Co., LLC | 6 | $120 |
| Kaleo, Inc. | 7 | $110 |
| Pharming Healthcare, Inc. | 5 | $93 |
| GC Biopharma USA, Inc. | 3 | $88 |
| Regeneron Healthcare Solutions, Inc. | 5 | $86 |
| Pfizer | 3 | $47 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $44 |
| Amgen | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Genentech USA, Inc. | 1 | $34 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| USWM, LLC | 1 | $20 |
| Ionis Pharmaceuticals, Inc. | 1 | $19 |
| Biocryst Pharmaceuticals, Inc. | 1 | $19 |
| ADMA Biomanufacturing LLC | 1 | $17 |
| Kedrion Biopharma, Inc. | 1 | $17 |
| Greer Laboratories, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Merck | 1 | $11 |
How this compares
Too few allergy/ immunology providers in Texasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 30 | $289,565 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $27,995 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 42 | $27,279 |
| XhanceFluticasone Propionate | 11 | $12,824 |
| Advair HfaFluticasone Propion/Salmeterol | 17 | $9,557 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $4,533 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 13 | $3,323 |
| Azelastine Hcl | 45 | $2,126 |
| Montelukast Sodium | 125 | $1,725 |
| Cefprozil | 17 | $590 |
| Ipratropium Bromide | 16 | $556 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $481 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $158 |
| Hydroxyzine Hcl | 13 | $156 |
| Prednisone | 63 | $150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $1,421 | $289,56530 claims |
| GSKTrelegy Ellipta | $1,119 | $27,99532 claims |
| AstraZenecaBreztri Aerosphere | $221 | $27,27942 claims |
| Optinose US, Inc.Xhance | $177 | $12,82411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy/ immunology providers in Texason file to place this against a meaningful peer group, so we don't.
Other allergy/ immunology in San Antonio
- John MastrovichSan Antonio$0
- William LumryDallas$1.3M
- Priyanka GuptaNew Braunfels$207K
- Keith PaullCollege Station$11K
- Jamie YeagerDallas$5K
- John van WagonerPlano$5K
- Pramila DaftaryWaco$3K
- Luis GonzalezEl Paso$2K
- Robert LekachBrownsville$310
- John YorkEl Paso$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.